Calamos Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-110,000
| Closed | -$8.48M | – | 1124 |
|
|
2022
Q1 | $8.48M | Buy |
110,000
+16,000
| +17% | +$1.23M | 0.03% | 553 |
|
|
2021
Q4 | $8.31M | Buy |
+94,000
| New | +$8.31M | 0.03% | 532 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 884 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 709 |
|
|
2020
Q3 | – | Sell |
-159,791
| Closed | -$19.7M | – | 687 |
|
|
2020
Q2 | $19.7M | Sell |
159,791
-1,500
| -0.9% | -$185K | 0.14% | 177 |
|
|
2020
Q1 | $13.6M | Buy |
+161,291
| New | +$13.6M | 0.11% | 221 |
|
|
2017
Q1 | – | Sell |
-292,378
| Closed | -$24.2M | – | 606 |
|
|
2016
Q4 | $24.2M | Sell |
292,378
-48,908
| -14% | -$4.05M | 0.19% | 156 |
|
|
2016
Q3 | $31.6M | Buy |
+341,286
| New | +$31.6M | 0.23% | 146 |
|
|
2014
Q3 | – | Sell |
-8,470
| Closed | -$527K | – | 625 |
|
|
2014
Q2 | $527K | Buy |
8,470
+2,070
| +32% | +$129K | ﹤0.01% | 580 |
|
|
2014
Q1 | $437K | Sell |
6,400
-1,900
| -23% | -$130K | ﹤0.01% | 576 |
|
|
2013
Q4 | $583K | Buy |
8,300
+3,900
| +89% | +$274K | ﹤0.01% | 568 |
|
|
2013
Q3 | $318K | Sell |
4,400
-5,300
| -55% | -$383K | ﹤0.01% | 566 |
|
|
2013
Q2 | $541K | Buy |
+9,700
| New | +$541K | ﹤0.01% | 507 |
|